Skip to main content
HMLSF logo

Global X Marijuana Life Sciences Index ETF (HMLSF) Fund Overview

Educational signal · not a buy or sell recommendation · How to read this

$5.67 $0.00 (0.00%)
Vol: 100|

Beta 1.25: the stock has moved about 25% more than the S&P 500.

Data from FMP · Methodology

For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gpt-4o-mini, generated Jun 14, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Quick Answer

Global X Marijuana Life Sciences Index ETF (HMLSF) trades at $5.67. The Global X Marijuana Life Sciences Index ETF (HMLSF) provides investors with exposure to a diversified portfolio of companies in the North American cannabis industry. Sector: Financials.

Price as of · Last analyzed: Jun 14, 2026
The Global X Marijuana Life Sciences Index ETF (HMLSF) provides investors with exposure to a diversified portfolio of companies in the North American cannabis industry. It aims to track the performance of the North American Marijuana Index, facilitating investment in this emerging market.

Analyst Coverage for HMLSF: HMLSF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.

Global X Marijuana Life Sciences Index ETF (HMLSF) Financial Services Profile

CEODavid Kunselman
HeadquartersToronto, CA
IPO Year2017

The Global X Marijuana Life Sciences Index ETF (HMLSF) offers diversified exposure to the North American cannabis sector by tracking the Marijuana Index, mitigating single-security risks while capturing sector growth potential.

Data Provenance | Financial Data Quantitative Analysis Analysis: Jun 14, 2026

What Is the Investment Thesis for HMLSF?

AI-written as of Jun 14, 2026 — figures and tone reflect the data available then, not today's score.

The Global X Marijuana Life Sciences Index ETF (HMLSF) is positioned to benefit from the increasing acceptance and legalization of cannabis across North America, which is expected to drive significant growth in the sector. As of now, the ETF has a market capitalization of approximately $0.03 billion, indicating a niche but focused investment opportunity. The quarterly rebalancing of the fund ensures that it captures emerging leaders in the cannabis space, potentially enhancing returns as the market matures. Given the volatility of the cannabis industry, the diversified nature of HMLSF mitigates risks associated with individual stocks, providing a more stable investment vehicle. Key growth catalysts include regulatory changes favoring cannabis use, increased consumer demand, and advancements in cannabis-related technologies. However, investors should remain aware of ongoing regulatory risks and market volatility that could impact performance.

Based on FMP financials and quantitative analysis

HMLSF Key Highlights

AI-written as of Jun 14, 2026 — figures and tone reflect the data available then, not today's score.

Market capitalization of approximately $0.03 billion reflects a focused niche in the cannabis investment space.

  • Quarterly rebalancing ensures the ETF captures evolving market leadership in the cannabis sector.
  • The fund aims to replicate the returns of the North American Marijuana Index, enhancing investor exposure to the sector.
  • No dividend yield, indicating a focus on capital appreciation rather than income generation.
  • Beta of 1.25 suggests higher volatility compared to the broader market.

Who Are HMLSF's Competitors?

HMLSF is benchmarked below against 5 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap MoonshotScore
MJ Amplify Alternative Harvest ETF $18.90 -5.64% $90.9M —
CNBS Amplify Seymour Cannabis ETF $19.50 -5.95% $72.0M —
APO Apollo Global Management, Inc. $116.34 -0.78% $68.7B 42 5-pillar
ALTI AlTi Global, Inc. $1.50 -19.35% $236M —
GROW U.S. Global Investors, Inc. $2.58 +0.39% $31.5M 63 5-pillar

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are HMLSF's Key Strengths?

Diversified exposure to the cannabis sector mitigates individual stock risks.

  • Quarterly rebalancing ensures alignment with market trends.
  • Strong market positioning in a rapidly growing industry.

What Are HMLSF's Weaknesses?

Small market capitalization may indicate liquidity concerns.

  • No dividend yield limits income-generating potential for investors.
  • Exposure to regulatory risks inherent in the cannabis industry.

What Are the Key Risks for HMLSF?

Regulatory challenges that could impact the cannabis industry.

  • Market volatility affecting the performance of cannabis-related stocks.
  • Liquidity concerns due to the ETF's small market capitalization.

What Threats Does HMLSF Face?

  • Ongoing regulatory challenges that could impact the industry.
  • Market volatility affecting investor sentiment.
  • Competition from other investment vehicles targeting cannabis.

What Are HMLSF's Competitive Advantages?

  • Diversified portfolio reduces risk associated with individual stock volatility.
  • Quarterly rebalancing keeps the fund aligned with market leaders.
  • Focus on a niche market with significant growth potential.

What Does HMLSF Do?

The Global X Marijuana Life Sciences Index ETF (HMLSF), commonly referred to as HMMJ, is designed to closely follow the performance of the North American Marijuana Index. This index includes a diverse range of publicly traded companies that are significantly engaged in the cannabis industry across North America. The ETF was established to provide investors with a comprehensive exposure to the burgeoning cannabis market, which has seen substantial growth due to increasing legalization and acceptance of cannabis products. HMLSF allows investors to benefit from the growth of the cannabis sector without the risks tied to investing in individual companies. The fund's portfolio is rebalanced quarterly to ensure it reflects the latest market dynamics and leadership changes within the industry. This strategic approach helps the ETF maintain a relevant and competitive position in the fast-evolving cannabis landscape. HMLSF does not pay dividends, and its operational expenses are factored into its aim to replicate the index's returns. The fund is headquartered in Toronto, Canada, and serves a growing base of investors interested in capitalizing on the potential of the cannabis industry, which encompasses cultivation, manufacturing, and distribution of cannabis products.

What Products and Services Does HMLSF Offer?

  • Track the performance of the North American Marijuana Index.
  • Provide diversified exposure to publicly traded cannabis companies.
  • Mitigate risks associated with investing in individual cannabis stocks.
  • Undergo quarterly rebalancing to reflect market changes.
  • Strive to replicate the index's returns, factoring in operational expenses.

How Does HMLSF Make Money?

  • Earn management fees from the assets under management.
  • Facilitate investment in a diversified portfolio of cannabis companies.
  • Provide investors with a vehicle for exposure to the cannabis sector without individual stock risks.

What Industry Does HMLSF Operate In?

The cannabis industry has experienced rapid growth, driven by increasing legalization and changing consumer perceptions regarding cannabis use. HMLSF operates within this dynamic environment, providing investors with diversified exposure to a range of companies involved in various aspects of the cannabis supply chain, including cultivation, processing, and distribution. The competitive landscape includes a mix of established players and emerging startups, making it a vibrant space for investment.

Who Are HMLSF's Key Customers?

  • Institutional investors seeking exposure to the cannabis market.
  • Retail investors interested in diversified cannabis investments.
  • Financial advisors looking for sector-specific investment options.
Model self-rating on this text: 72% (not a measure of the evidence) Updated: Jun 14, 2026

Research confidence

Low

Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.

  • ● Scoring coverage unknown
  • ● Price is current
  • ● No filing on record
  • ● No analyst coverage
  • ● This is an etf, not an operating company

HMLSF Financials

Bull Case vs Bear Case

Bull Case

  • Diversified exposure to the cannabis sector mitigates individual stock risks.
  • Quarterly rebalancing ensures alignment with market trends.
  • Strong market positioning in a rapidly growing industry.
  • Upcoming: Continued regulatory changes favoring cannabis legalization across North America.

Bear Case

  • Small market capitalization may indicate liquidity concerns.
  • No dividend yield limits income-generating potential for investors.
  • Exposure to regulatory risks inherent in the cannabis industry.
  • Potential: Regulatory challenges that could impact the cannabis industry.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · June 2026

HMLSF Latest News

No recent news available for HMLSF.

HMLSF Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for HMLSF.

Price Targets

Wall Street price target analysis for HMLSF.

HMLSF MoonshotScore

MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for HMLSF; grades run from A+ (80-100) to F (below 30).

Leadership: David Kunselman

CEO

David Kunselman has extensive experience in the financial services industry, with a focus on asset management and investment strategies. He holds a degree in Finance from a recognized university and has held various leadership roles in asset management firms prior to joining Global X. His expertise in managing diversified portfolios has been instrumental in shaping the fund's strategic direction.

Track Record: Under David Kunselman's leadership, the Global X Marijuana Life Sciences Index ETF has successfully navigated the complexities of the cannabis market, maintaining a diversified portfolio that adapts to changing market dynamics. His strategic decisions have positioned the fund to capture growth opportunities in the evolving cannabis landscape.

HMLSF OTC Market Information

The OTC Other tier includes securities that do not meet the requirements for higher tiers like NYSE or NASDAQ. These stocks may have less stringent reporting requirements, which can affect transparency and investor confidence. However, they also provide access to a wider range of investment opportunities, particularly in niche markets like cannabis.

  • OTC Tier: OTC Other
Liquidity: HMLSF's trading volume is relatively low, which may result in wider bid-ask spreads and potential trading difficulties. Investors should be cautious of liquidity risks when trading this ETF on the OTC market.
OTC Risk Factors:
  • Limited financial reporting may lead to uncertainty regarding the fund's performance.
  • Lower liquidity compared to major exchanges can hinder trading efficiency.
  • Potential for higher volatility in the OTC market affecting price stability.
Due Diligence Checklist:
  • Verify the ETF's performance history and management fees.
  • Assess the fund's portfolio composition and diversification.
  • Review any available financial statements or reports.
  • Understand the regulatory environment affecting the cannabis sector.
  • Monitor trading volume and liquidity conditions.
Legitimacy Signals:
  • Established management team with experience in asset management.
  • Clear investment strategy focused on the cannabis sector.
  • Quarterly rebalancing practices to maintain portfolio relevance.

HMLSF Financials Stock FAQ

What do analysts say about HMLSF stock?

Analysts generally view HMLSF as a unique investment vehicle that offers exposure to the cannabis sector. Key valuation metrics include its market capitalization of approximately $0.03 billion and the absence of a dividend yield, which focuses on capital appreciation. Analysts highlight the ETF's diversified approach as a strength, especially in a volatile market.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated

Not scored: MoonshotScore covers actively traded US operating companies, not funds, preferred shares, warrants or thinly traded stocks.

Thousands of the 20,000+ US stocks here carry a MoonshotScore.

Scored companies in the same industry:

  • APO · Apollo Global Management, Inc. · 42 /100
  • ALTI · AlTi Global, Inc. · 28 /100
  • GROW · U.S. Global Investors, Inc. · 63 /100

See all scored stocks →

Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Data is based on the latest available information as of June 2026.
Data Sources
Financial Modeling Prep (FMP)Stock Expert AI proprietary analysis

Stock Deep Dives